Will BWX Ltd Go Down Anytime Soon?

 Will BWX Ltd Go Down Anytime Soon?

The stock of BWX Ltd (ASX:BWX) is a huge mover today! The stock increased 5.05% or $0.2 on November 18, hitting $4.16. About 489,456 shares traded hands or 40.70% up from the average. BWX Ltd (ASX:BWX) has declined 8.97% since April 22, 2016 and is downtrending. It has underperformed by 13.40% the S&P500.
The move comes after 7 months positive chart setup for the $384.89M company. It was reported on Nov, 18 by Barchart.com. We have $7.28 PT which if reached, will make ASX:BWX worth $288.67 million more.

More notable recent BWX Ltd (ASX:BWX) news were published by: Fool.com.Au which released: “BWX Ltd reports strong growth but shares get hammered: Should you buy?” on August 16, 2016, also Fool.com.Au with their article: “Is BWX Ltd a bargain buy after falling 18% in the last month?” published on November 07, 2016, Fool.com.Au published: “Why BWX Ltd shares are soaring on its maiden profit result” on February 10, 2016. More interesting news about BWX Ltd (ASX:BWX) were released by: Fool.com.Au and their article: “BWX Ltd shares go gangbusters on Boots UK distribution deal” published on July 26, 2016 as well as Fool.com.Au‘s news article titled: “Here’s why the Bellamy’s Australia Ltd, Vitaco Holdings Ltd, and BWX Ltd share …” with publication date: April 12, 2016.

BWX Limited is a developer, manufacturer, distributor and marketer of skin and hair care products with a focus on the natural segment of the beauty and personal care market. The company has a market cap of $384.89 million. The Firm owns, produces and distributes products under the Sukin, Derma Sukin, USpa, Edward Beale and Renew Skincare brands. It has a 31.78 P/E ratio. The Firm operates in the Hair and Beauty Products segment, which is engaged in the manufacture, wholesale and distribution sale, and the development of natural body, hair and skin care products.

Receive News & Ratings Via Email - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings with our FREE daily email newsletter.

Related posts

Leave a Comment